Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement

Bor Sheng Ko, Cheng Shyong Chang, Ming Chih Chang, Tsai-Yun Chen, Tzeon Jye Chiou, Chang Fang Chiu, Wen Li Huang, Woei Yau Kao, Yii Jenq Lan, Shen Fung Lin, Tran Der Tan, Jih Luh Tang, Cheng Hwai Tzeng, Po Nan Wang, Su Pen Yet, Hwei Fang Tien

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalInternational Journal of Hematology
Volume100
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Iron Overload
Myelodysplastic Syndromes
Taiwan
Guidelines
Chelation Therapy
Iron
Physicians

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Ko, Bor Sheng ; Chang, Cheng Shyong ; Chang, Ming Chih ; Chen, Tsai-Yun ; Chiou, Tzeon Jye ; Chiu, Chang Fang ; Huang, Wen Li ; Kao, Woei Yau ; Lan, Yii Jenq ; Lin, Shen Fung ; Tan, Tran Der ; Tang, Jih Luh ; Tzeng, Cheng Hwai ; Wang, Po Nan ; Yet, Su Pen ; Tien, Hwei Fang. / Guidelines for treating iron overload in myelodysplastic syndromes : A Taiwan consensus statement. In: International Journal of Hematology. 2014 ; Vol. 100, No. 1. pp. 7-15.
@article{440ee64b3f444e9baac2d82c09adda59,
title = "Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement",
abstract = "Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.",
author = "Ko, {Bor Sheng} and Chang, {Cheng Shyong} and Chang, {Ming Chih} and Tsai-Yun Chen and Chiou, {Tzeon Jye} and Chiu, {Chang Fang} and Huang, {Wen Li} and Kao, {Woei Yau} and Lan, {Yii Jenq} and Lin, {Shen Fung} and Tan, {Tran Der} and Tang, {Jih Luh} and Tzeng, {Cheng Hwai} and Wang, {Po Nan} and Yet, {Su Pen} and Tien, {Hwei Fang}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s12185-014-1607-x",
language = "English",
volume = "100",
pages = "7--15",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "1",

}

Ko, BS, Chang, CS, Chang, MC, Chen, T-Y, Chiou, TJ, Chiu, CF, Huang, WL, Kao, WY, Lan, YJ, Lin, SF, Tan, TD, Tang, JL, Tzeng, CH, Wang, PN, Yet, SP & Tien, HF 2014, 'Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement', International Journal of Hematology, vol. 100, no. 1, pp. 7-15. https://doi.org/10.1007/s12185-014-1607-x

Guidelines for treating iron overload in myelodysplastic syndromes : A Taiwan consensus statement. / Ko, Bor Sheng; Chang, Cheng Shyong; Chang, Ming Chih; Chen, Tsai-Yun; Chiou, Tzeon Jye; Chiu, Chang Fang; Huang, Wen Li; Kao, Woei Yau; Lan, Yii Jenq; Lin, Shen Fung; Tan, Tran Der; Tang, Jih Luh; Tzeng, Cheng Hwai; Wang, Po Nan; Yet, Su Pen; Tien, Hwei Fang.

In: International Journal of Hematology, Vol. 100, No. 1, 01.01.2014, p. 7-15.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Guidelines for treating iron overload in myelodysplastic syndromes

T2 - A Taiwan consensus statement

AU - Ko, Bor Sheng

AU - Chang, Cheng Shyong

AU - Chang, Ming Chih

AU - Chen, Tsai-Yun

AU - Chiou, Tzeon Jye

AU - Chiu, Chang Fang

AU - Huang, Wen Li

AU - Kao, Woei Yau

AU - Lan, Yii Jenq

AU - Lin, Shen Fung

AU - Tan, Tran Der

AU - Tang, Jih Luh

AU - Tzeng, Cheng Hwai

AU - Wang, Po Nan

AU - Yet, Su Pen

AU - Tien, Hwei Fang

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

AB - Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

UR - http://www.scopus.com/inward/record.url?scp=84904309011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904309011&partnerID=8YFLogxK

U2 - 10.1007/s12185-014-1607-x

DO - 10.1007/s12185-014-1607-x

M3 - Review article

C2 - 24924953

AN - SCOPUS:84904309011

VL - 100

SP - 7

EP - 15

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 1

ER -